CA2304005A1 - Compositions and methods for treating respiratory disorders - Google Patents

Compositions and methods for treating respiratory disorders Download PDF

Info

Publication number
CA2304005A1
CA2304005A1 CA002304005A CA2304005A CA2304005A1 CA 2304005 A1 CA2304005 A1 CA 2304005A1 CA 002304005 A CA002304005 A CA 002304005A CA 2304005 A CA2304005 A CA 2304005A CA 2304005 A1 CA2304005 A1 CA 2304005A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
composition according
cold
alpha
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002304005A
Other languages
English (en)
French (fr)
Inventor
Sekhar Mitra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2304005A1 publication Critical patent/CA2304005A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002304005A 1997-09-19 1998-08-28 Compositions and methods for treating respiratory disorders Abandoned CA2304005A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93403397A 1997-09-19 1997-09-19
US08/934,033 1997-09-19
PCT/IB1998/001339 WO1999015173A1 (en) 1997-09-19 1998-08-28 Compositions and methods for treating respiratory disorders

Publications (1)

Publication Number Publication Date
CA2304005A1 true CA2304005A1 (en) 1999-04-01

Family

ID=25464848

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002304005A Abandoned CA2304005A1 (en) 1997-09-19 1998-08-28 Compositions and methods for treating respiratory disorders

Country Status (12)

Country Link
EP (1) EP1014983A1 (pt)
JP (1) JP2001517626A (pt)
KR (1) KR20010024187A (pt)
CN (1) CN1278728A (pt)
AU (1) AU8744398A (pt)
BR (1) BR9812660A (pt)
CA (1) CA2304005A1 (pt)
CO (1) CO5011084A1 (pt)
HU (1) HUP0004813A2 (pt)
NO (1) NO20001412D0 (pt)
PE (1) PE118999A1 (pt)
WO (1) WO1999015173A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03001437A (es) * 2000-09-08 2005-06-03 Warner Lambert Co Prevencion de sinusitis aguda y crisis sinusal.
CN1518448A (zh) * 2001-06-20 2004-08-04 ���鹫˾ 用于治疗鼻充血和鼻塞的抗组胺剂
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
CL2003002653A1 (es) 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20050192355A1 (en) * 2004-02-17 2005-09-01 Wyeth Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
CN101073563B (zh) * 2007-02-07 2010-10-06 西安利君制药有限责任公司 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片
GB0719518D0 (en) * 2007-10-05 2007-11-14 Therapeutics Ltd E Therapy
US8252330B2 (en) 2009-01-05 2012-08-28 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
CA2748728C (en) 2009-01-05 2017-01-03 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
US8246988B2 (en) 2009-01-05 2012-08-21 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
GB0905954D0 (en) * 2009-04-06 2009-05-20 E Therapeutics Plc Treatment of exacerbations of asthma
CN103446587A (zh) * 2011-12-28 2013-12-18 汪明 肥大细胞抑制剂在制备抗流感病毒感染药物中的应用
CN103251590B (zh) * 2013-05-13 2014-12-17 中国科学院武汉病毒研究所 一种琥珀酸多西拉敏在制备治疗或预防流感病毒药物中的应用
KR102597910B1 (ko) * 2015-03-26 2023-11-02 재클린 엠. 이베르센 숙취상태와 연관된 증상들을 억제하기 위한 방법 및 조성물
CN109464670B (zh) * 2017-09-08 2022-08-02 中国科学院微生物研究所 调控a型和b型流感病毒核蛋白出核的关键氨基酸位点及其作为抗流感病毒药物靶点的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5260073A (en) * 1990-05-21 1993-11-09 Norwich Eaton Pharmaceuticals, Inc. Use of phenylpropanolamine as a mucus secretogogue in the upper airways
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
JPH11510168A (ja) * 1995-07-28 1999-09-07 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders

Also Published As

Publication number Publication date
CN1278728A (zh) 2001-01-03
KR20010024187A (ko) 2001-03-26
AU8744398A (en) 1999-04-12
PE118999A1 (es) 2000-02-03
CO5011084A1 (es) 2001-02-28
JP2001517626A (ja) 2001-10-09
WO1999015173A1 (en) 1999-04-01
EP1014983A1 (en) 2000-07-05
HUP0004813A2 (hu) 2001-08-28
NO20001412D0 (no) 2000-03-17
BR9812660A (pt) 2000-08-22

Similar Documents

Publication Publication Date Title
AU7604094A (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
US5648358A (en) Compositions and methods for treating respiratory disorders
CA2304005A1 (en) Compositions and methods for treating respiratory disorders
JP2019019132A (ja) 安定な医薬組成物
JPH08502288A (ja) 感昌症状を治療するための医薬組成物及び用法
CA2170485C (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
EP0841947A1 (en) Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
EP0674527A1 (en) Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
IE913184A1 (en) Method for treating respiratory disorders
AU672279B2 (en) Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
JP3987501B2 (ja) 医薬組成物
JPH083066A (ja) かぜ薬製剤
JP2013049729A (ja) 医薬組成物
JP2017114789A (ja) 医薬組成物
WO2013018766A1 (ja) 安定な医薬組成物
JP2023072015A (ja) ロキソプロフェン含有去痰医薬組成物
EP1267861A2 (en) Composition comprising paracetamol and niflumic acid
JP2007039473A (ja) 医薬組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued